(NYSE: IQV) Iqvia Holdings's forecast annual revenue growth rate of 4.54% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.71%.
Iqvia Holdings's revenue in 2025 is $15,497,000,000.On average, 9 Wall Street analysts forecast IQV's revenue for 2025 to be $2,770,219,244,000, with the lowest IQV revenue forecast at $2,736,754,470,000, and the highest IQV revenue forecast at $2,795,963,720,000. On average, 9 Wall Street analysts forecast IQV's revenue for 2026 to be $2,915,079,756,000, with the lowest IQV revenue forecast at $2,873,486,750,000, and the highest IQV revenue forecast at $2,969,718,000,000.
In 2027, IQV is forecast to generate $3,064,327,894,000 in revenue, with the lowest revenue forecast at $3,002,788,680,000 and the highest revenue forecast at $3,164,123,290,000.